[Verse 1]
Nineteen eighty-six, Geneva conference hall
WHO dropped a ladder on the analgesic wall
Three rungs climbing upward, non-opioid first
Mild to moderate, quench that nociceptive thirst
Step one's aspirin, acetaminophen, NSAIDs
Step two adds codeine, tramadol if the patient needs
Step three brings morphine, oxycodone, full agonist power
But critics said the ladder crumbled in the cancer pain hour
Said it missed interventional, left the neuraxial out
So now a fourth step handles what the rungs couldn't rout
Spinal cord stimulators, intrathecal infusion lines
The ladder grew a penthouse floor with interventional designs
[Chorus]
WHO ladder, three steps plus a fourth we added on
CDC twenty-twenty-two says non-opioid's where you belong
Lowest dose, immediate-release, don't initiate with ER
Reassess your patient, don't discontinue cold or hard
MME is your calculus, your risk thermometer reading
Fifty's a caution flag, ninety's where the danger's bleeding
Canadian, NICE, Australian — they rhyme but diverge in the weeds
Know your framework, know your guideline, know exactly what your patient needs
[Verse 2]
CDC dropped twenty-twenty-two, rewrote the clinical script
No hard dose ceilings, but every principle is equipped
Non-opioid therapy first — that's the cardinal decree
Multimodal approaches before you hand the opioid key
Immediate-release formulations when you're starting out
Not extended-release, never start with the long-acting route
Acute pain duration — three days often does the deed
Seven days the ceiling for most presentations of need
Reassess, reassess — check function, check the pain score
Avoid abrupt discontinuation, taper or you'll cause more harm than before
[Verse 3]
Now let's parse the MME — morphine milligram equivalent math
A conversion currency to track the opioid dosage path
Oral morphine is the anchor, every drug converts across
Hydrocodone one-to-one, hydromorphone costs you more
Oxycodone multiply by one-point-five to translate
Fentanyl patches demand a different conversion rate
But here's the shibboleth — the word that marks the knowing few
Buprenorphine's partial agonist ceiling breaks the MME through
Methadone's half-life curves in ways that calculators can't define
Both excluded from the standard table by pharmacokinetic design
Fifty MME daily raises the clinician's brow
Ninety MME triggers naloxone co-prescription now
[Bridge]
Canadian guidelines emphasize the functional taper and tread
NICE in the UK draws harder lines on long-term opioid spread
Faculty of Pain Medicine in Australia stresses informed consent
Each framework agrees on risk but not where every boundary's meant
The divergence isn't failure — it's epidemiology speaking different dialects
Regional data shapes the guidance, context shapes what the evidence reflects